Medicine & Life Sciences
Primary Myelofibrosis
100%
Polycythemia Vera
95%
Hospitalists
67%
Neoplasms
50%
Essential Thrombocythemia
48%
Galectin 3
43%
Symptom Assessment
35%
Coronavirus
34%
INCB018424
30%
Quality of Life
30%
Pandemics
30%
Janus Kinase Inhibitors
28%
SARS Virus
28%
Vaccines
28%
Vaccination
24%
pomalidomide
22%
Peptides
21%
Therapeutics
20%
Physicians
20%
Fatigue
19%
Social Isolation
19%
Messenger RNA
19%
Syntex adjuvant formulation
18%
Splenomegaly
17%
Congenital Adrenal Hyperplasia
17%
Severe Acute Respiratory Syndrome
16%
Internal Medicine
15%
Infections
14%
Systematic Reviews
14%
Guidelines
13%
Hydroxyurea
13%
Confidence Intervals
13%
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
13%
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
13%
Anxiety
13%
Delivery of Health Care
12%
Physician Assistants
11%
Opioid Epidemic
11%
Lung
11%
Extraskeletal Myxoid Chondrosarcoma
11%
polypeptide N-acetylgalactosaminyltransferase
10%
Length of Stay
10%
Hematocrit
10%
Electronic Health Records
10%
Internet
10%
Nontuberculous Mycobacterium Infections
10%
Epithelioid Hemangioendothelioma
9%
Thrombocytopenia
9%
Patient Reported Outcome Measures
9%
Mycobacterium abscessus
9%
Meta-Analysis
9%
Stem Cells
9%
Opioid Analgesics
9%
Hospital Medicine
9%
Thrombosis
9%
Coronavirus Infections
9%
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
9%
Pneumonia
9%
Virilism
9%
Abdominal Abscess
8%
Massive Hepatic Necrosis
8%
Anemia
8%
Human Adenoviruses
8%
Healthcare-Associated Pneumonia
8%
Nontuberculous Mycobacteria
8%
Telemetry
8%
Echocardiography
8%
Biopsy
8%
Isoelectric Point
8%
Allogeneic Cells
8%
Lectins
7%
Amiodarone
7%
Phlebotomy
7%
Burkitt Lymphoma
7%
Logistic Models
7%
Patient Care
7%
Sexuality
7%
Molecular Cloning
7%
Patient Readmission
7%
Carcinoid Tumor
7%
Carbohydrates
7%
Homologous Transplantation
7%
Threonine
7%
Substrate Specificity
7%
Seroepidemiologic Studies
7%
Portal Hypertension
7%
Histocompatibility Antigens Class II
7%
Janus Kinases
7%
Carisoprodol
7%
Mortality
7%
Peritoneal Dialysis
7%
Thymocytes
7%
Ascites
7%
Tobacco Use
6%
Mechanics
6%
Fedratinib
6%
B-Cell Lymphoma
6%
Peritonitis
6%
Bone Marrow Transplantation
6%
Sweat
6%